PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsFlatulence
MeSH D005414 - flatulence
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012817:Digestive signs and symptoms
0 Companies
0 Drugs
Success rate
D005414: 
Flatulence
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Johnson & JohnsonLoperamide, Simethicone Imodium Multi-symptom  1996-06-26   
PerrigoLoperamide, Simethicone Loperamide Simethicone  2002-08-30   
Aurobindo PharmaLoperamide, Simethicone Loperamide Simethicone  2020-12-14   
Sun Pharmaceutical IndustriesLoperamide, Simethicone Loperamide Simethicone  2006-09-06   
HeteroLoperamide, Simethicone Loperamide Simethicone  2021-06-17   
BionPharmaLoperamide, Simethicone Loperamide Simethicone  2021-09-10   
Granules PharmaceuticalsLoperamide, Simethicone Loperamide Simethicone  2022-08-29   
Bracco DiagnosticsSimethicone-cellulose Sonorx  1998-10-29   
Innovative Drug Delivery SystemsLoperamide, Simethicone Loperamide Simethicone  2021-05-27   
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Johnson & Johnson
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use